Why is circulating tumour DNA testing used in liquid biopsy?

Tumour cells can release small fragments of DNA into the bloodstream. A laboratory analyses the blood sample for selected genetic changes or tumour signals. The result may help a cancer team identify a change that could influence treatment selection, monitor how tumour-related signals change over time, or investigate whether disease may still be detectable after treatment. A blood result is interpreted alongside scans, examination findings and any tissue pathology; it does not replace every biopsy.

Ask which question the test is intended to answer and whether a tissue sample is also needed. Tell the team about previous cancer treatment and bring relevant pathology or scan reports if requested. The blood draw is usually arranged by the treating team, and the laboratory may need time to confirm whether enough relevant DNA was found for analysis. A result that finds no detectable signal does not by itself prove that cancer is absent.

Contact your oncology team if you develop new or worsening symptoms, or if you are unsure how a result affects your next appointment. Seek urgent medical help for severe breathing difficulty, chest pain, confusion, heavy bleeding or sudden weakness. The test itself does not diagnose every cause of a symptom, so symptoms need their own clinical assessment.

What genetic changes will this test assess? Could the result change my treatment? If the blood test is inconclusive, would tissue testing or another scan be useful? When and how will the result be explained?